
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence.
The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.
Drug developers are increasingly adopting AI for discovery and safety testing to get faster and cheaper results, in line with the U.S. Food and Drug Administration's push to reduce animal testing in the near future.
Drug development software maker Certara and biotechs such as Schrodinger and Recursion Pharmaceuticals are using the booming technology to predict how experimental drugs might be absorbed, distributed or trigger toxic side-effects.
"We believe the Cell Atlas is a key development that will enable us to significantly scale AI for drug discovery," said Illumina CEO Jacob Thaysen.
The Atlas will capture how 1 billion individual cells respond to genetic changes via CRISPR across more than 200 disease-relevant cell lines.
These cell lines have been selected for their relevance to diseases, many of which have been historically difficult to decode, including immune disorders and cancer as well as cardiometabolic, neurological and rare genetic diseases.
The Atlas will enable users to characterize drug and disease mechanisms of action, explore potential new indications and validate candidate targets from human genetics.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
latest_posts
- 1
The Response Uncovered: Disentangling the Secrets of the Universe - 2
Spanish woman, 25, dies by legal euthanasia in case that drew national spotlight - 3
Netflix is releasing a documentary on Elizabeth Smart. What to know about her kidnapping, rescue and where she is now. - 4
Anger as German family business group opens talks with far-right AfD - 5
Honda’s Biggest Flex Isn’t Its Superbikes, It’s Selling 500K Bikes In One Month
Is an $85 apple pie worth it? Our Thanksgiving taste test says … maybe.
Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
Netflix Faces Wider Fallout After Italy Court Orders Refunds, Price Cuts
New studies of old dogs help scientists understand where they came from
Understanding climate change in America: Skepticism, dogmatism and personal experience
What we know about Renee Nicole Good, the woman who was killed by an ICE officer in Minneapolis
Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
Russian billionaire says 12-hour days and 6-day workweeks could help save the economy
Scientists captured female sperm whales on video working together during a birth to protect the calf











